INS and metabolic dysfunction-associated steatotic liver disease: In current study, we found that women aged 35–45 with NAFLD had significantly lower estrogen levels than the controls, while they also had higher BMI, waist circumference, insulin and triglyceride levels, indicating that decreased estrogen is a factor that promotes NALFD.